Current available therapies and future directions in the treatment of malignant gliomas
Annick Desjardins1,2, David A Reardon1,3, James J Vredenburgh1,21The Preston Robert Tisch Brain Tumor Center; 2Department of Medicine; 3Department of Surgery, Duke University Medical Center, Durham, NC, USAAbstract: The prognosis of patients diagnosed with malignant glioma (MG) remains poor. However...
Enregistré dans:
Auteurs principaux: | Annick Desjardins, David A Reardon, James J Vredenburgh |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f28bd4fe4a054f819c5dc43eb35249c7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Galectins in Glioma: Current Roles in Cancer Progression and Future Directions for Improving Treatment
par: Samy Ajarrag, et autres
Publié: (2021) -
Regenerative nanomedicine: current perspectives and future directions
par: Chaudhury K, et autres
Publié: (2014) -
Magnetic particle imaging: current developments and future directions
par: Panagiotopoulos N, et autres
Publié: (2015) -
Nanotherapeutics in the EU: an overview on current state and future directions
par: Hafner A, et autres
Publié: (2014) -
Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles
par: Orza A, et autres
Publié: (2013)